IRadimed
Market Cap
US$239.1m
Last Updated
2020/04/08 07:16 UTC
Data Sources
Company Financials +
Executive Summary
IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible medical devices, and related accessories and services in the United States and internationally.
Rewards
Risk Analysis
Snowflake Analysis
Flawless balance sheet with solid track record.
Similar Companies
Share Price & News
How has IRadimed's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: IRMD's share price has been volatile over the past 3 months.
Market Performance
7 Day Return
0.9%
IRMD
3.7%
US Medical Equipment
2.4%
US Market
1 Year Return
-26.7%
IRMD
-1.6%
US Medical Equipment
-10.0%
US Market
Return vs Industry: IRMD underperformed the US Medical Equipment industry which returned -1.6% over the past year.
Return vs Market: IRMD underperformed the US Market which returned -10% over the past year.
Shareholder returns
| IRMD | Industry | Market | |
|---|---|---|---|
| 7 Day | 0.9% | 3.7% | 2.4% |
| 30 Day | -10.1% | -5.6% | -11.0% |
| 90 Day | -20.9% | -14.5% | -19.4% |
| 1 Year | -26.7%-26.7% | -0.8%-1.6% | -8.1%-10.0% |
| 3 Year | 141.7%141.7% | 50.7%46.6% | 17.3%9.6% |
| 5 Year | 29.3%29.3% | 81.9%63.2% | 36.1%21.1% |
Price Volatility Vs. Market
How volatile is IRadimed's share price compared to the market and industry in the last 5 years?
Simply Wall St News
2 days ago | Simply Wall St
A Close Look At IRadimed Corporation’s (NASDAQ:IRMD) 14% ROCE3 weeks ago | Simply Wall St
How Does IRadimed's (NASDAQ:IRMD) P/E Compare To Its Industry, After The Share Price Drop?3 weeks ago | Simply Wall St
Boasting A 17% Return On Equity, Is IRadimed Corporation (NASDAQ:IRMD) A Top Quality Stock?Valuation
Is IRadimed undervalued compared to its fair value and its price relative to the market?
33.7%
Undervalued compared to fair value
Share Price vs. Fair Value
Below Fair Value: IRMD ($20.06) is trading below our estimate of fair value ($30.26)
Significantly Below Fair Value: IRMD is trading below fair value by more than 20%.
Price To Earnings Ratio
PE vs Industry: IRMD is good value based on its PE Ratio (23.5x) compared to the Medical Equipment industry average (38.5x).
PE vs Market: IRMD is poor value based on its PE Ratio (23.5x) compared to the US market (13x).
Price to Earnings Growth Ratio
PEG Ratio: IRMD is poor value based on its PEG Ratio (1.1x)
Price to Book Ratio
PB vs Industry: IRMD is overvalued based on its PB Ratio (4.3x) compared to the US Medical Equipment industry average (3x).
Next Steps
Future Growth
How is IRadimed forecast to perform in the next 1 to 3 years based on estimates from 1 analyst?
22.2%
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: IRMD's forecast earnings growth (22.2% per year) is above the savings rate (1.7%).
Earnings vs Market: IRMD's earnings (22.2% per year) are forecast to grow faster than the US market (13.3% per year).
High Growth Earnings: earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: IRMD's revenue (19.6% per year) is forecast to grow faster than the US market (7% per year).
High Growth Revenue: IRMD's revenue (19.6% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if IRMD's Return on Equity is forecast to be high in 3 years time
Next Steps
Past Performance
How has IRadimed performed over the past 5 years?
7.9%
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: IRMD has high quality earnings.
Growing Profit Margin: IRMD's current net profit margins (25%) are higher than last year (20.7%).
Past Earnings Growth Analysis
Earnings Trend: IRMD's earnings have grown by 7.9% per year over the past 5 years.
Accelerating Growth: IRMD's earnings growth over the past year (52.8%) exceeds its 5-year average (7.9% per year).
Earnings vs Industry: IRMD earnings growth over the past year (52.8%) exceeded the Medical Equipment industry 1.4%.
Return on Equity
High ROE: IRMD's Return on Equity (17.3%) is considered low.
Next Steps
Financial Health
How is IRadimed's financial position?
Financial Position Analysis
Short Term Liabilities: IRMD's short term assets ($59.0M) exceed its short term liabilities ($5.9M).
Long Term Liabilities: IRMD's short term assets ($59.0M) exceed its long term liabilities ($5.3M).
Debt to Equity History and Analysis
Debt Level: IRMD is debt free.
Reducing Debt: IRMD had no debt 5 years ago.
Debt Coverage: IRMD has no debt, therefore it does not need to be covered by operating cash flow.
Interest Coverage: IRMD has no debt, therefore coverage of interest payments is not a concern.
Balance Sheet
Next Steps
Dividend
What is IRadimed's current dividend yield, its reliability and sustainability?
Dividend Yield vs Market
Notable Dividend: Unable to evaluate IRMD's dividend yield against the bottom 25% of dividend payers, as the company has not reported any payouts.
High Dividend: Unable to evaluate IRMD's dividend yield against the top 25% of dividend payers, as the company has not reported any payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if IRMD's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if IRMD's dividend payments have been increasing.
Current Payout to Shareholders
Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of IRMD's dividend in 3 years as they are not forecast to pay a notable one for the US market.
Next Steps
Management
How experienced are the management team and are they aligned to shareholders interests?
6.3yrs
Average management tenure
CEO
Leslie McDonnell (46yo)
0.67
Tenure
Ms. Leslie L. McDonnell has been Vice President and General Manager of Newborn Care Business Unit at Natus Medical Incorporated since joining it on February 12, 2018. Ms. McDonnell served as Global Busines ...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Founder | 3.83yrs | US$494.58k | 48.34% $115.6m | |
| CFO & Secretary | 6.33yrs | US$508.45k | 0.18% $421.9k | |
| President | 0.67yr | no data | no data | |
| Vice President of Worldwide Sales | 0.25yr | no data | no data | |
| Controller | 15.25yrs | no data | 0.29% $702.1k |
6.3yrs
Average Tenure
56.5yo
Average Age
Experienced Management: IRMD's management team is seasoned and experienced (6.3 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Founder | 3.83yrs | US$494.58k | 48.34% $115.6m | |
| President | 0.67yr | no data | no data | |
| Independent Director | 0.83yr | US$35.50k | no data | |
| Independent Director | 4.08yrs | US$152.50k | 0.14% $327.8k | |
| Independent Director | 6.25yrs | US$155.00k | 0.18% $426.9k |
3.8yrs
Average Tenure
66yo
Average Age
Experienced Board: IRMD's board of directors are considered experienced (3.8 years average tenure).
Ownership
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: IRMD insiders have only sold shares in the past 3 months.
Recent Insider Transactions
Ownership Breakdown
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 4.9%.
Top Shareholders
Company Information
IRadimed Corporation's company bio, employee growth, exchange listings and data sources
Key Information
- Name: IRadimed Corporation
- Ticker: IRMD
- Exchange: NasdaqCM
- Founded: 1992
- Industry: Health Care Equipment
- Sector: Healthcare
- Market Cap: US$239.109m
- Shares outstanding: 11.92m
- Website: https://www.iradimed.com
Number of Employees
Location
- IRadimed Corporation
- 1025 Willa Springs Drive
- Winter Springs
- Florida
- 32708
- United States
Listings
| Ticker | Exchange | Primary Security | Security Type | Country | Currency | Listed on |
|---|---|---|---|---|---|---|
| IRMD | NasdaqCM (Nasdaq Capital Market) | Yes | Common Shares | US | USD | Jul 2014 |
| 46K | BST (Boerse-Stuttgart) | Yes | Common Shares | DE | EUR | Jul 2014 |
| 46K | DB (Deutsche Boerse AG) | Yes | Common Shares | DE | EUR | Jul 2014 |
Biography
IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible medical devices, and related accessories and services in the United States and internationally. It offers MRI compatible intravenous (IV) infusion pump system with associated disposable IV tubing sets; and MRI compatible patient vital signs monitoring system. The company also offers IV poles, wireless remote displays/controls, side car pump modules, dose error reduction systems, and SpO2 monitoring with sensors and accessories. It serves hospitals, acute care facilities, and outpatient imaging centers. The company sells its products through direct field sales representatives, regional sales directors, clinical support representatives, and independent distributors. IRADIMED CORPORATION was incorporated in 1992 and is headquartered in Winter Springs, Florida.Â
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2020/04/08 07:16 |
| End of Day Share Price | 2020/04/07 00:00 |
| Earnings | 2019/12/31 |
| Annual Earnings | 2019/12/31 |
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.